Diss. (sammanfattning) Uppsala : Univ., 2004. / Härtill 6 uppsatser.

Endochondral ossification is the process of skeletal bone growth via the formation of a cartilage template that subsequently undergoes mineralization to form trabecular bone. Genetic mutations affecting the proliferation or differentiation of chondrocytes result in skeletal abnormalities. Activating transcription factor-2 (ATF-2) modulates expression of cell cycle regulatory genes in chondrocytes, and mutation of ATF-2 results in a dwarfed phenotype. Here we investigate the regulatory role that ATF-2 plays in expression of the pocket proteins, cell cycle regulators important in cellular proliferation and differentiation. The spatial and temporal pattern of pocket protein expression was identified in wild type and mutant growth plates. Expression of retinoblastoma (pRb) mRNA and protein were decreased in ATF-2 mutant primary chondrocytes. pRb mRNA expression was coordinated with chondrogenic differentiation and cell cycle exit in ATDC5 cells. Type X collagen immunohistochemistry was performed to visualize a delay in differentiation in response to loss of ATF-2 signaling. Chondrocyte proliferation was also affected by loss of ATF-2. These studies suggest pRb plays a role in chondrocyte proliferation, differentiation and growth plate development by modulating cell cycle progression. ATF-2 regulates expression of pRb within the developing growth plate, contributing to the skeletal phenotype of ATF-2 mutant mice through the regulation of chondrocyte proliferation and differentiation.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第19223号 / 医博第4022号 / 新制||医||1010(附属図書館) / 32222 / 京都大学大学院医学研究科医学専攻 / (主査)教授 妻木 範行, 教授 開 祐司, 教授 松田 秀一 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第21047号 / 薬科博第90号 / 新制||薬科||10(附属図書館) / 京都大学大学院薬学研究科薬科学専攻 / (主査)教授 竹島 浩, 教授 中山 和久, 教授 金子 周司 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM

A osteoaderina (OSAD) tem sido identificada nos tecidos mineralizados, porém, seu papel na mineralização óssea não está claro. Foi feita uma comparação do momento em que a OSAD aparece na ossificação intramembranosa e endocondral, em relação aos estágios iniciais de mineralização. O osso parietal de fetos de ratos Wistar com 17, 18 e 21 dias e o côndilo mandibular de ratos com 30 dias foram removidos. A expressão de OSAD foi analisada por imunocitoquímica e Western blotting. Nos dois tipos de ossificação, a imunomarcação foi detectada nos osteoblastos; porém, na matriz extracelular a OSAD apareceu somente na fase fibrilar de mineralização, mantendo-se constante posteriormente. A análise por Western blotting revelou que os fetos com 17 dias continham pouco menos OSAD que os de 18 dias, enquanto a imunorreatividade diminuía nos fetos com 21 dias. Os resultados sugerem que a OSAD tem um papel na mineralização da matriz, atuando, provavelmente como organizadora de seu arcabouço ou retendo o mineral, além de exercer atividades de adesão entre os componentes da matriz. / Osteoadherin (OSAD) had been identified in mineralized tissues, but its specific role in mineralization remains unclear. The present study compared the appearance of OSAD at early stages of mineralization during both intramembranous and endochondral ossification. Parietal bone of 17, 18 and 21 days-old fetus and mandibular condyle of 30 days-old Wistar rats were removed. The expression of OSAD was analyzed by immunocytochemistry and Western blotting. In both types of ossification the labeling was uniformly distributed in the cytoplasm of osteoblasts but it only appeared in the mineralizing matrix when the fibrilar stage was taking place, remaining as a component of the mineralized bone matrix. Western blots revealed that 17-days-old embryos contained slightly less OSAD than 18- days-old fetus, while immunoreactivity was weak in 21 days-old fetus. The results suggest that OSAD plays a role in collagen fibril mineralization maybe by organizing the matrix assembly or by retaining the mineral into the matrix, besides exerting binding activities among its components.

La dysplasie géléophysique (DG) est une maladie rare qui appartient à la famille des dysplasies acroméliques. Cette pathologie est caractérisée par un retard statural, une brachydactylie, une raideur articulaire, une dysmorphie faciale, une peau épaisse, une atteinte bronchopulmonaire et une surcharge valvulaire cardiaque conduisant le plus souvent à une mort précoce dans les premières années de la vie. Deux modes de transmissions ont été identifiés. Le premier autosomique récessif est dû à des mutations dans le gène ADAMTSL2. Le second, autosomique dominant est dû à un hot-spot de mutations dans les exons 41 et 42 qui codent pour le domaine Transforming Growth Factor (TGF) β-binding protein-like domain 5 (TB5) du gène FBN1. FBN1 et ADAMTSL2 codent pour des protéines sécrétées de la matrice extracellulaire (MEC). FBN1 code pour la fibrilline-1, une composante des microfibrilles qui jouent un rôle dans la biodisponibilité du TGFβ. La protéine ADAMTSL2 fait partie de la famille des ADAMTS mais n’a pas d’activité enzymatique dû à l’absence de domaine catalytique. Sa fonction est encore inconnue. Cependant des partenaires d’ADAMTSL2 ont été identifiés par notre équipe : latent-transforming growth factor beta-binding protein 1 (LTBP1) et FBN1 qui sont directement impliqués dans le stockage de TGFβ. Récemment une autre protéine, FBN2, a aussi été découverte comme partenaire d’ADAMTSL2 (Hubmacher D et. al.). L’objectif de ma thèse était de comprendre le mécanisme physiopathologique de la DG, grâce à l’analyse de modèles murins. Un premier modèle murin pour la forme récessive de la DG appelé CreCMV; Adamtsl2f/f (ou KO) a été généré. L’analyse phénotypique de ces souris a montré un retard statural, des os longs courts, des extrémités courtes. Dans les plaques de croissance des os longs des souris mutantes, nous avons observé une désorganisation des colonnes chondrocytaires associée à une diminution de l’expression du collagène de type 10, marqueur de la différentiation des chondrocytes. L’analyse de la matrice extracellulaire des plaques de croissance a révélé une désorganisation structurale importante. Une diminution de la fibrilline-1 et de LTBP-1 a été observée ainsi qu’une augmentation de l’activation de la voie de signalisation TGFβ au niveau de la plaque de croissance des souris mutantes. Nous avons observé une désorganisation du réseau microfibrillaire sur des cultures de chondrocytes de souris mutantes. Ces résultats nous ont permis de suggérer que la protéine ADAMTSL2 est impliquée dans la structure du réseau microfibrillaire, lieu de stockage du TGFβ et de démontrer un rôle majeur d’ADAMTSL2 dans la régulation de la chondrogenèse. Afin d’étudier la forme dominante de la DG, le modèle FBN1TB5+/- a été généré. Il est issu d’un système knock-in avec une mutation dans l’exon 42 du gène fbn1 qui correspond au domaine TB5 de la fibrilline-1. Nos résultats ont montré une réduction de la taille des souris hétérozygotes et homozygotes en comparaison aux souris sauvages au stade P1 et P30. Au stade P1, nous avons observé des chondrocytes plus larges et une dérégulation des marqueurs de la chondrogenèse au niveau de la plaque de croissance des fémurs des souris hétérozygotes, ainsi que chez les souris homozygotes. De plus, nous avons observé une très forte mortalité des souris homozygotes vers l’âge de 2 ou 3 mois. Nous en avons conclu que des mutations domaine TB5 de la fibrilline étaient liées à un retard statural et donc que FBN1 avait un rôle majeur dans la chondrogenèse. / Geleophysic dysplasia (GD) is a rare disease, which belong to acromelic group. This pathology is characterized by short stature, brachydactyly, joint stiffness, thick skin, facial dimorphism, broncho-pulmonary insufficiency and cardiac disease which lead to an early death in the first years of life. Two mode of inheritance have been identified. The first one, autosomal recessive, is due to mutations in ADAMTSL2 gene. The second, autosomal dominant, is due to hot-spot mutations in exon 41-42 of FBN1 gene, which encode the Transforming Growth Factor (TGF) β-binding protein-like domain 5 (TB5) of the protein. FBN1 and ADAMTSL2 encode secreted proteins of the extracellular matrix (ECM). FBN1 encodes fibrilline-1, component of microfibrillar network, playing a role in the bioavailability of TGF- β. ADAMTSL2 protein belongs to ADAMTS family, but does not have enzymatic activity due to lack of catalytic domain. Its function remains unknown. However, ADAMTSL2 partners have been identified by our team: latent-transforming growth factor beta-binding protein 1 (LTBP1) and FBN1, which are directly implied in storage of TGF-β. Recently, another protein, FBN2, have been identified as an ADAMTSL2 partner (Hubmacher D et. al.). The aim of my study was to understand the physiopathological mechanism of Geleophysic dysplasia by analysing murine models. A first murine model for the GD recessive form, CreCMV; Adamtsl2f/f (KO), have been generated. Phenotypic analysis of these mice showed short stature and shorter long bones and extremities. In long bone growth plate of mutant mice, we observed disorganization of chondrocyte columns, associated with decrease of collagen 10 expression, marker of chondrocyte differentiation. Analysis of ECM in growth plate revealed strong structural disorganization. Decrease of FBN1 and LTBP1 and were observed with an overactivation of TGF-β pathway in growth plate of mutant mice. We observed disorganization of microfibrillar network in chondrocyte cultures of mutant mice. These results suggest that ADAMTSL2 protein is implied in structure of microfibrillar network, where is stored TGF-β, and demonstrate major role of ADAMTSL2 in chondrogenesis. In order to study dominant form of GD, mouse model FBN1TB5+/-, have been generated. The mice were obtained by knock-in system, with mutation in exon 42 of FBN1 gene. Our results showed short stature of heterozygous (HT) and homozygous (Ho) mice compared to wild)type mice, at stage P1 and P30. At stage P1, we observed larger chondrocytes and deregulation of chondrogenesis markers in growth plate of HT and Ho mice. Furthermore, we observed high mortality of Ho mice at 2-3 months. We concluded that mutations in TB5 domain of FBN1 were linked to short stature and thus FBN1 have major role in chondrogenesis.

The growth plate resting zone consists of hyaline-like chondrocytes disbursed in a proteoglycan rich extracellular matrix. These cells give rise to the columns of the growth zone, consisting of progressively hypertrophic cells. Proliferation of resting zone chondrocytes induced by systemic and local stimuli is the driving force of longitudinal growth of long bones. Therefore, homeostasis of this cell population has great importance. Although the regulation of proliferation and differentiation of these cells has been well studied, little is known about the regulation of their apoptosis. We have previously shown that chelerythrine and tamoxifen induce apoptosis in resting zone chondrocytes in a nitric oxide (NO)-dependent pathway. In this study we explored two physiological apoptogens: inorganic phosphate (Pi) and 17β-estradiol (E₂). We found NO production is necessary in Pi-induced apoptosis. We also found that NO donors induced chondrocyte apoptosis by up-regulating p53 expression, Bax/Bcl-2 expression ratio and cytochrome C release from mitochondria, as well as caspase-3 activity, indicating that NO induces chondrocyte apoptosis in a mitochondrial pathway. Mitogen activated protein kinase (MAPK) activity was involved. A c-Jun N-terminal kinase (JNK) inhibitor, but not inhibitors of p38 or extracellular signal-regulated kinase (ERK1/2), was able to block NO-induced apoptosis, indicating that JNK is necessary in this pathway. Taken together, Pi elevates NO production, which leads to a mitochondrial apoptotic pathway dependent on JNK. On the other hand, although E₂caused apoptosis in resting zone chondrocytes in a dose-dependent manner, up-regulated p53 and Bax, and induced release of cytochrome C from the mitochondria, which indicated a mitochondrial apoptotic pathway, the apoptosis did not involve elevated nitric oxide production or MAPK as was found in Pi-induced apoptosis. This study elucidates the signaling pathway underlying Pi and E₂-induced chondrocyte apoptosis. It has important implications on understanding the development of mammalian growth plate. It also provides further information about the physiological functions of estrogen on longitudinal bone growth.

A osteoaderina (OSAD) tem sido identificada nos tecidos mineralizados, porém, seu papel na mineralização óssea não está claro. Foi feita uma comparação do momento em que a OSAD aparece na ossificação intramembranosa e endocondral, em relação aos estágios iniciais de mineralização. O osso parietal de fetos de ratos Wistar com 17, 18 e 21 dias e o côndilo mandibular de ratos com 30 dias foram removidos. A expressão de OSAD foi analisada por imunocitoquímica e Western blotting. Nos dois tipos de ossificação, a imunomarcação foi detectada nos osteoblastos; porém, na matriz extracelular a OSAD apareceu somente na fase fibrilar de mineralização, mantendo-se constante posteriormente. A análise por Western blotting revelou que os fetos com 17 dias continham pouco menos OSAD que os de 18 dias, enquanto a imunorreatividade diminuía nos fetos com 21 dias. Os resultados sugerem que a OSAD tem um papel na mineralização da matriz, atuando, provavelmente como organizadora de seu arcabouço ou retendo o mineral, além de exercer atividades de adesão entre os componentes da matriz. / Osteoadherin (OSAD) had been identified in mineralized tissues, but its specific role in mineralization remains unclear. The present study compared the appearance of OSAD at early stages of mineralization during both intramembranous and endochondral ossification. Parietal bone of 17, 18 and 21 days-old fetus and mandibular condyle of 30 days-old Wistar rats were removed. The expression of OSAD was analyzed by immunocytochemistry and Western blotting. In both types of ossification the labeling was uniformly distributed in the cytoplasm of osteoblasts but it only appeared in the mineralizing matrix when the fibrilar stage was taking place, remaining as a component of the mineralized bone matrix. Western blots revealed that 17-days-old embryos contained slightly less OSAD than 18- days-old fetus, while immunoreactivity was weak in 21 days-old fetus. The results suggest that OSAD plays a role in collagen fibril mineralization maybe by organizing the matrix assembly or by retaining the mineral into the matrix, besides exerting binding activities among its components.

Résumé: Le muscle squelettique possède une excellente capacité à se regénérer notamment grâce à ses cellules progénitrices stromales (mrSC) et myogéniques (CPM). À la suite de certains traumas et pour des raisons encore méconnues, la qualité de sa régénération est compromise ce qui mène à l’apparition de structures aberrantes tel l’os mature, aussi appelée ossification hétérotopique (OH) post-traumatique. Notre laboratoire a montré dans un modèle murin que les mrSC sont pleinement impliquées dans cette pathologie. De plus, un facteur fortement ostéoinducteur, BMP9, ne cause l’OH que si, et seulement si, le muscle est endommagé. Ce modèle d’étude est unique puisqu’il présente les particularités physiopathologiques de l’OH post-traumatique, un dommage du muscle étant essentiel à la formation d’os. De plus, ce modèle a permis de mettre en évidence le rôle prédominant du microenvironnement des cellules progénitrices dans le développement de cette pathologie. Nous avons donc émis l’HYPOTHÈSE selon laquelle le microenvironnement du muscle endommagé contient des facteurs qui peuvent influencer le phénotype de ses cellules progénitrices stromales et myogéniques favorisant ainsi le développement de l’OH. Nos résultats montrent que l’état hypoxique d’un muscle sévèrement endommagé augmente la prolifération et la différenciation ostéogénique des mrSC. De plus, l’hypoxie induit spécifiquement l’expression de BMP9 par les mrSC. L’impact de BMP9 a également été évalué sur la différenciation des CPM. Les résultats montrent qu’à des concentrations physiologiques, BMP9 inhibe le potentiel myogénique des CPM en faveur d’une différenciation ostéogénique, et cela tant dans la lignée myoblastique murine C2C12 que chez les CPM primaires humaines. En résumé, le muscle endommagé développant l’OH possède un microenvironement spécifique responsable du débalancement de la capacité régénérative de ses progéniteurs. Nos travaux montrent que ce microenvironnement cause un retard de la myogenèse et une ostéogenèse où participeront non seulement les mrSC mais également les CPM. L’identification et la compréhension des mécanismes régulant ces facteurs s’avèrent clé pour offrir aux cliniciens des outils de diagnostic mais également des alternatives ou des approches complémentaires aux traitements prophylaxiques actuels. / Abstract: Skeletal muscle has an extraordinary ability to regenerate due to its resident stromal cells (mrSCs) and myogenic progenitor cells (MPCs). Following certain traumas, the quality of the regeneration of skeletal muscle can be compromised for unknown reasons, leading to the appearance of aberrant structures such as mature bone, a process called posttraumatic heterotopic ossification (HO). Our laboratory developed a mouse model to show that mrSCs are fully involved in this pathology. We also showed that BMP9, a highly osteoinductive factor, causes HO if and only if the muscle is damaged. This model is unique in that it recapitulates the pathophysiological features of post-traumatic HO in which muscle damage is essential for bone formation. The model was also used to show that the progenitor cell microenvironment plays a predominant role in the development of this pathology. Based on these results, we HYPOTHESIZED that the microenvironment of the damaged muscle contains factors that can influence the phenotype of its progenitor cell populations, thus promoting the development of HO. Our results showed that the hypoxic state of a severely damaged muscle increases the proliferation and osteogenic differentiation of mrSCs and also specifically induces the expression of BMP9 by mrSCs. The impact of BMP9 on the differentiation of MPCs was also evaluated. At physiological concentrations, BMP9 inhibited the myogenic differentiation potential of murine myoblast C2C12 cells and primary human MPCs, and triggered their differentiation into an osteogenic lineage. In summary, we showed that damaged muscle that develops HO has a specific microenvironment that is responsible for the loss of the regenerative capacity of progenitor cells, leading to a delay in myogenesis, and that mrSCs and MPCs are both involved in osteogenesis. The identification and understanding of the mechanisms regulating these key factors could provide clinicians with valuable diagnostic tools as well as alternative and/or complementary approaches to current prophylactic treatments.

La périostine est une protéine matricellulaire préférentiellement exprimée aux sites de contraintes mécaniques, notamment le périoste, et dans le stroma associé à de nombreux types de cancers. En premier lieu, nous nous sommes attachés à évaluer la pertinence de cette protéine en tant que biomarqueur du métabolisme osseux et de la réaction stromale dans les métastases osseuses. Nous avons développé le premier dosage ELISA de la périostine circulante chez la souris présentant des caractéristiques analytiques (spécificité, précision) conformes aux exigences réglementaires. Ce dosage nous a permis de préciser l’implication de la périostine dans le métabolisme osseux et les métastases osseuses de cancer du sein. Nos données in vitro et in vivo suggèrent que la périostine n’est pas un indice direct du remodelage osseux, contrairement aux marqueurs biologiques conventionnels, mais une composante de l’ossification primaire. Nous avons aussi montré dans les métastases osseuses d’origine mammaire que la périostine est surexprimée par les cellules stromales de la métastase, comme cela a pu être observé au niveau des tumeurs primaires. Enfin, nous avons confirmé par une approche bioinformatique la relation étroite entre périostine et réaction stromale dans la plupart des tumeurs chez l’Homme. La périostine et d’autres protéines conjointement exprimées pourraient donc constituer un panel de marqueurs biologiques de la progression tumorale, certains pouvant se révéler comme nouvelles cibles thérapeutiques en oncologie. / Periostin is a matricellular protein preferentially expressed at sites subjected to mechanical constraints, including the periosteum, and in the stroma associated to several tumor types. We first aimed to evaluate the relevance of periostin as a biomarker of bone metabolism or stromal reaction in bone metastases. We developed the first ELISA for serum periostin in mouse with analytical characteristics (specificity, precision) that are in accordance with regulatory standards. This ELISA allowed us to specify further the involvement of periostin in bone metabolism and breast cancer bone metastases. Our in vitro and in vivo data suggested that periostin is a component of primary ossification rather than a direct index of bone remodeling, unlike conventional bone markers. In breast cancer bone metastases, we also showed that periostin is overexpressed by stromal cells associated with bone metastasis, in agreement with its localization in the stroma of primary tumors. Finally, using bioinformatics analyses of large datasets from various tumors in human, we confirmed the close relationship between periostin and the stromal reaction. Periostin and other co-expressed proteins could therefore constitute a set of biological markers of cancer progression, and/or appear as potential therapeutic targets.